Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study

The Lancet Oncology
Kate SimmsKaren Canfell

Abstract

Cervical screening and human papillomavirus (HPV) vaccination have been implemented in most high-income countries; however, coverage is low in low-income and middle-income countries (LMICs). In 2018, the Director-General of WHO announced a call to action for the elimination of cervical cancer as a public health problem. WHO has called for global action to scale-up vaccination, screening, and treatment of precancer, early detection and prompt treatment of early invasive cancers, and palliative care. An elimination threshold in terms of cervical cancer incidence has not yet been defined, but an absolute rate of cervical cancer incidence could be chosen for such a threshold. In this study, we aimed to quantify the potential cumulative effect of scaled up global vaccination and screening coverage on the number of cervical cancer cases averted over the 50 years from 2020 to 2069, and to predict outcomes beyond 2070 to identify the earliest years by which cervical cancer rates could drop below two absolute levels that could be considered as possible elimination thresholds-the rare cancer threshold (six new cases per 100 000 women per year, which has been observed in only a few countries), and a lower threshold of four new cases per 1...Continue Reading

Citations

Dec 10, 2019·Clinical Obstetrics and Gynecology·Emily K Hill
Apr 5, 2019·Current Opinion in Obstetrics & Gynecology·Brian J Morris
Mar 10, 2020·International Journal of Cancer. Journal International Du Cancer·Sophie PilleronMarion Piñeros
Jul 25, 2020·International Journal of Cancer. Journal International Du Cancer·Emily A BurgerJane J Kim
Feb 2, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·A SantaballaJ Bayo
Apr 28, 2020·British Journal of Cancer·Elima Jedy-AgbaDonald Maxwell Parkin
Jul 10, 2020·Vaccines·Masayuki SekineTakayuki Enomoto
Aug 3, 2020·Archives of Gynecology and Obstetrics·Anna M DückelmannJalid Sehouli
Aug 6, 2020·Frontiers in Immunology·Xu ZhouYang Lin
Nov 7, 2019·Dose-response : a Publication of International Hormesis Society·Chang Liu, Rensheng Wang
Aug 8, 2020·Molecular Biology Reports·Jie JiMing-Bing Xiao
May 15, 2020·Molecular Biology Reports·Alejandro Montoya-GómezEliécer Jiménez-Charris
Sep 18, 2020·The Journal of Infectious Diseases·Karin Sundström, Joakim Dillner
Oct 1, 2020·International Journal of Cancer. Journal International Du Cancer·Ju-Fang ShiWanqing Chen
Oct 1, 2020·International Journal of Cancer. Journal International Du Cancer·Jesper BondeDaniëlle A M Heideman
Dec 5, 2020·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Wiebren A A Tjalma
Nov 18, 2020·Gynecologic Oncology·Erik E L JansenInge M C M de Kok
Jan 16, 2021·Irish Journal of Medical Science·Maeve HaranMike Scully
Nov 20, 2020·The Lancet Global Health·Dominik StelzleShona Dalal
Sep 15, 2019·Gynécologie, Obstétrique, Fertilité & Sénologie·C GonthierG Canlorbe
Dec 23, 2020·Emerging Infectious Diseases·Iacopo BaussanoGary M Clifford
Nov 1, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Annabelle BrennanMartha Hickey
Jan 13, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Mark Jit

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Lancet Infectious Diseases
Shevanthi NayagamTimothy B Hallett
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Lindsey A TorreAhmedin Jemal
International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics
Sanchia ArandaVivien Davis Tsu
© 2022 Meta ULC. All rights reserved